ST. LOUIS, Jan. 10, 2024 /PRNewswire/ -- Sabai Group LLC ('Sabai'), a provider of custom solutions for biosafety and human research protections, today announced the acquisition of Alpha Independent Review Board, LLC ('Alpha IRB'). Headquartered in San Clemente, CA, Alpha IRB provides Institutional Review Board ('IRB') services for biopharma sponsors, CROs, and site networks conducting clinical trials.

圣路易斯，2024年1月10日/PRNewswire/--Sabai Group LLC（“Sabai”）是生物安全和人类研究保护定制解决方案的提供商，今天宣布收购Alpha Independent Review Board，LLC（“Alpha IRB”）。Alpha IRB总部位于加利福尼亚州圣克莱门特，为生物制药赞助商、CRO和进行临床试验的网站网络提供机构审查委员会（“IRB”）服务。

Founder and CEO of Alpha IRB, Marianne Thornton, has joined Sabai's Board of Directors..

Alpha IRB创始人兼首席执行官玛丽安·桑顿（MarianneTornton）已加入萨拜董事会。。

Sabai's acquisition of Alpha IRB marks a significant milestone in the growth and expansion of both companies. Alpha IRB's bench of talented IRB professionals and board members has deep experience in growing therapeutic areas that complements not only Sabai's existing IRB capabilities, but also its Institutional Biosafety Committee ('IBC') and cell-gene therapy focused service offerings.

萨拜收购Alpha IRB标志着两家公司增长和扩张的一个重要里程碑。Alpha IRB的IRB专业人才和董事会成员在不断发展的治疗领域拥有丰富的经验，不仅可以补充Sabai现有的IRB能力，还可以补充其机构生物安全委员会（“IBC”）和以细胞基因治疗为重点的服务。

No changes to existing Alpha or Sabai contracts is necessary at this time as a result of this acquisition. .

此次收购不需要对现有阿尔法或萨拜合同进行任何变更。。

'Alpha IRB and Sabai share a distinguished patient first culture within the regulatory and ethical review sector, making this partnership a natural fit. Alpha IRB's late-stage multi-center review experience, coupled with Sabai's early-stage experience in oncology, cell and gene therapy, and infectious disease, increases the breadth of regulatory review for our clients and further enhances our 'white glove' approach in supporting drug development trials.

“Alpha IRB和Sabai在监管和道德审查部门拥有卓越的患者至上文化，这使这种合作关系自然适合。Alpha IRB的晚期多中心审查经验，加上Sabai在肿瘤学，细胞和基因治疗以及传染病方面的早期经验，增加了我们客户监管审查的广度，并进一步增强了我们支持药物开发试验的“白手套”方法。

Even more organizations will now be able to experience the Sabai approach of leading with science and distinguishing with service,' said Michael Keens, Chief Executive Officer of Sabai..

萨拜岛首席执行官迈克尔·基恩斯（MichaelKeens）说，现在，更多的组织将能够体验到萨拜岛以科学引领、以服务区分的方法。。

'Joining Sabai is a great result for patients as well as our clients and employees,' said Marianne Thornton, founder of Alpha IRB. 'Both organizations share a deep focus on patient protection and scientific expertise as well as strong customer service – together, we can bring our expert services reflecting those core values to an even wider range of clinical research stakeholders.'.

Alpha IRB创始人玛丽安·桑顿（MarianneTornton）说，加入萨拜（Sabai）对患者、客户和员工来说都是一个很好的结果这两个组织都非常关注患者保护和科学专业知识以及强大的客户服务，我们可以将反映这些核心价值观的专家服务带给更广泛的临床研究利益相关者。”。

'We're excited to bring these two distinguished organizations together,' said Chris Jenkins, founder and Chief Scientific Officer of Sabai. 'Alpha IRB's experience in late phase trials nicely complements Sabai's industry leading scientific expertise and exemplary service.'

Sabai创始人兼首席科学官克里斯·詹金斯（ChrisJenkins）说，我们很高兴能将这两个杰出的组织聚集在一起阿尔法IRB在后期试验中的经验很好地补充了萨拜工业领先的科学专业知识和示范服务。”

About Alpha IRB

关于Alpha IRB

Alpha IRB specializes in ethical review and human research protections through AAHRPP-accredited IRB services for clinical trial sponsors, CROs, sites and institutions. Alpha IRB was founded in 2007 and is headquartered in San Clemente, CA.

Alpha IRB通过AAHRPP认证的IRB服务专门为临床试验赞助商、CRO、网站和机构提供伦理审查和人类研究保护。Alpha IRB成立于2007年，总部位于加利福尼亚州圣克莱门特。

About SabaiSabai specializes in custom solutions for biosafety and human research protections through IRB, IBC, and consulting services. Headquartered in Chesterfield, MO, Sabai's biosafety and ethical review experts have supported their biotech, pharma, and device partners since 2017.

关于SabaiSabai专门通过IRB、IBC和咨询服务为生物安全和人类研究保护提供定制解决方案。萨拜的生物安全和伦理审查专家总部位于密苏里州切斯特菲尔德，自2017年以来一直支持其生物技术，制药和设备合作伙伴。

Contact: Sarah Attwood[email protected]

联系人：Sarah Attwood[受电子邮件保护]

SOURCE Sabai Group LLC

SOURCE Sabai集团有限责任公司